Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $2.1 billion.

  • Neurocrine Biosciences' Non-Current Assets rose 575.73% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.4 billion, marking a year-over-year increase of 2077.0%. This contributed to the annual value of $2.1 billion for FY2025, which is 575.73% up from last year.
  • As of Q4 2025, Neurocrine Biosciences' Non-Current Assets stood at $2.1 billion, which was up 575.73% from $2.1 billion recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' Non-Current Assets ranged from a high of $2.1 billion in Q2 2025 and a low of $761.0 million during Q1 2021
  • Over the past 4 years, Neurocrine Biosciences' median Non-Current Assets value was $1.6 billion (recorded in 2023), while the average stood at $1.5 billion.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 19262.37% in 2021, then skyrocketed by 575.73% in 2025.
  • Quarter analysis of 4 years shows Neurocrine Biosciences' Non-Current Assets stood at $1.0 billion in 2021, then soared by 62.55% to $1.6 billion in 2023, then increased by 21.26% to $2.0 billion in 2024, then grew by 5.76% to $2.1 billion in 2025.
  • Its Non-Current Assets stands at $2.1 billion for Q4 2025, versus $2.1 billion for Q3 2025 and $2.1 billion for Q2 2025.